1'-乙基酸盐选择性降低瘤缩因子受体-关联因子2 (TRAF2) 表达的调节
Chihiro Moriwaki1, Shingo Takahashi1, Nhat Thi Vu1
1Department of Applied Biology, Kyoto Institute of Technology, Matsugasaki, Sakyo-ku, Kyoto 606-8585, Japan.
Molecules (Basel, Switzerland)
|March 27, 2025
概括
1'-乙酸乙 (ACA) 通过降低TRAF2蛋白表达的调节来抑制NF-κB通路. 这种天然化合物提供了抑制肺腺癌细胞炎症反应的潜在机制.
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 众所周知,1'-乙氧沙维醇 (ACA) 是一种来自Zingiberaceae的天然化合物,可以抑制核因子 κB (NF-κB) 信号通路.
- 通过ACA对NF-κB产生抑制作用的精确分子机制在很大程度上仍未被阐明.
研究的目的:
- 研究在人类肺腺癌A549细胞中ACA抑制NF-κB信号通路的分子机制.
- 为了确定特定的分子点和受ACA治疗影响的途径.
主要方法:
- 人类肺腺癌A549细胞被用ACA和瘤坏死因子-α (TNF-α) 治疗.
- 评估了细胞间粘附分子-1 (ICAM-1) 的表达,mRNA水平和促进剂活性.
- 使用西式涂抹分析分析了NF-κB信号通路组件,包括NF-κBα (IκBα) 抑制剂和TNF受体相关因子2 (TRAF2) 蛋白质水平.
- 在ACA诱导的TRAF2下调中蛋白质体降解的作用使用MG-132进行了检查.
主要成果:
- 在A549细胞中,ACA降低了TNF-α诱导的ICAM-1表达及其相关的mRNA和促进子活动.
- ACA 抑制了 TNF-α 诱导的 IκBα 蛋白质降解.
- ACA选择性地降低了TNF受体相关因子2 (TRAF2) 蛋白质表达的蛋白质依赖性,而不影响其他上游信号组件.
- 在人类纤维素瘤HT-1080细胞中也观察到ACA对TRAF2的下调.
结论:
- ACA通过通过蛋白质酶体降解选择性降低TRAF2蛋白表达的调节来抑制NF-κB信号通路.
- 这项研究提供了ACA涉及TRAF2下调机制的第一个证据,为其潜在的治疗应用提供了见解.
- 这些发现突出了ACA作为调节NF-κB途径调节炎症反应的潜在代理.
更多相关视频
10:49A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects TEdeff in Cancers
Published on: September 26, 2019
5.5K
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
9.1K
相关概念视频
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
The Extrinsic Apoptotic Pathway
5.7K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
5.7K
